Cited by 124Stress Responses and CortisolAlzheimer's disease research and treatmentsMemory and Neural Mechanisms

Interactions Between Age, Stress and Insulin on Cognition: Implications for Alzheimer's Disease

Open access
Solas, Maite, Aisa, Bárbara, Mugueta, María C, Del Río, Joaquín, Tordera, Rosa M, Ramírez, María J·2010·Neuropsychopharmacology

Abstract

There is much interest in understanding the mechanisms responsible for interactions among stress, aging, memory and Alzheimer's disease. Glucocorticoid secretion associated with early life stress may contribute to the variability of the aging process and to the development of neuro- and psychopathologies. Maternal separation (MS), a model of early life stress in which rats experience 3 h of daily separation from the dam during the first 3 weeks of life, was used to study the interactions between stress and aging. Young (3 months) MS rats showed an altered hypothalamic-pituitary-adrenal (HPA) axis reactivity, depressive-like behavior in the Porsolt swimming test and cognitive impairments in the Morris water maze and new object recognition test that persisted in aged (18 months) rats. Levels of insulin receptor, phosphorylated insulin receptor and markers of downstream signaling pathways (pAkt, pGSK3 beta, pTau, and pERK1 levels) were significantly decreased in aged rats. There was a significant decrease in pERK2 and in the plasticity marker ARC in MS aged rats compared with single MS or aged rats. It is interesting to note that there was a significant increase in the C99 : C83 ratio, A beta levels, and BACE1 levels the hippocampus of MS aged rats, suggesting that in aged rats subjected to early life stress, there was an increase in the amyloidogenic processing of amyloid precursor protein (APP). These results are integrated in a tentative mechanism through which aging interplay with stress to influence cognition as the basis of Alzheimer disease (AD). The present results may provide the proof-of-concept for the use of glucocorticoid-/insulin-related drugs in the treatment of AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2010.13

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Depressive symptoms may be direct manifestations of AD pathophysiology at the preclinical stage, prior to the onset of mild cognitive impairment.

    “Depressive symptoms may be direct manifestations of AD pathophysiology at the preclinical stage, prior to the onset of mild cognitive impairment [37–39].”

    From APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline (2021) · cites this paper as [37]

    The Introduction describes major depression as a risk factor for developing AD, not as a direct manifestation of preclinical AD pathophysiology. Searches for depressive symptoms as a prodrome and for mild cognitive impairment found no passage addressing whether symptoms occur before its onset. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Davis S, Laroche S (2006). Mitogen-activated protein kinase/ extracellular regulated kinase signaling and memory stabiliza- tion: a review. Genes Brain Behav 5: 61-72.
  2. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D (2006). Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63: 530-538.
  3. Paxinos G, Watson C (1982). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego.

Cited by

Sorted by citations

Authors
Solas, M., Aisa, B., Mugueta, M. C., Del Río, J., Tordera, R. M., & Ramírez, M. J.
Affiliations
Centro de Investigación Médica Aplicada (ES)
Corresponding author
Ramírez, María J
Venue
Neuropsychopharmacology
Published
2010-02-24
Volume
35
Issue
8
Pages
1664-1673
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W1965352353
Cited by
124
References
8
Citations by year
2026: 3 · 2025: 10 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 8 · 2018: 12 · 2017: 12 · 2016: 9 · 2015: 8 · 2014: 6 · 2013: 13 · 2012: 8
FWCI
3.78
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Deposito Adademico Digital Universidad De Navarra (University of Navarra) (submittedVersion, other-oa)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Keywords
Alzheimer's disease, early life stress, maternal separation, aging, insulin signaling, glucocorticoids, hypothalamic-pituitary-adrenal axis, cognitive impairment, APP processing, amyloid-beta, BACE1, insulin receptor, ERK1/2, Arc, hippocampus, depression
MeSH terms
Aging, Animals, Animals, Newborn, Cognition Disorders, Corticosterone, Cytoskeletal Proteins, Depression, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, Gene Expression Regulation, Hypothalamo-Hypophyseal System, Insulin, Insulin-Like Growth Factor I, Male, Maternal Deprivation, Motor Activity, Nerve Tissue Proteins, Neuropsychological Tests, Peptide Fragments, Pituitary-Adrenal System, Pregnancy, Receptor, Insulin, RNA, Messenger, Stress, Psychological, Swimming, Signal Transduction, Amyloid beta-Peptides, Rats, Wistar, Statistics, Nonparametric, Maze Learning, Brain-Derived Neurotrophic Factor, Recognition, Psychology, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review